BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//American Liver Foundation - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://liverfoundation.org
X-WR-CALDESC:Events for American Liver Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240301T000000
DTEND;TZID=America/New_York:20250329T235959
DTSTAMP:20260420T191601
CREATED:20240805T211801Z
LAST-MODIFIED:20250327T163642Z
UID:10001298-1709251200-1743292799@liverfoundation.org
SUMMARY:Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma (GEA)
DESCRIPTION:We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better understand established and emerging data related to HER2-targeted therapies in GEA. This on-demand course is available for continuing education credit until 3/29/25. \nUpon completion of this activity\, participants will: \n\nHave increased knowledge regarding the\n\nBiological rationale for using bispecific antibodies to target HER2 in GEA\n\n\nHave greater competence related to\n\nSelecting the most appropriate anti-HER2 therapy for a patient with HER2-positive GEA\nManaging adverse events associated with anti-HER2 therapies for patients with HER2-positive GEA\n\n\nDemonstrate greater confidence in their ability to\n\nCollaborate with the patient when developing a treatment plan for their HER2-positive GEA\n\n\n\nLearn more and register for this course: https://liver.fyi/HER2GEA \n 
URL:https://liver.fyi/HER2GEA#new_tab
LOCATION:On-Demand
CATEGORIES:Programs
ATTACH;FMTTYPE=image/png:https://liverfoundation.org/wp-content/uploads/2024/08/Fact-Sheet-What-Does-Your-Liver-Do.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241113T163000
DTEND;TZID=America/New_York:20241113T171500
DTSTAMP:20260420T191601
CREATED:20240820T154625Z
LAST-MODIFIED:20240916T143204Z
UID:10001156-1731515400-1731518100@liverfoundation.org
SUMMARY:Are You at Risk for Liver Cancer? Ask the Experts
DESCRIPTION:Join us for an insightful webinar exploring the unique aspects of liver cancer within the Black / African American communities. This session will cover key factors including prevalence\, risk factors\, cultural influences\, and strategies for effective prevention and treatment. Expert speakers will provide valuable information as well as host a live question and answer session at the end.  \n\n\n\nEvent Date: November 13th\, 2024Event Time: 4:30 p.m. ESTZoom Meeting Link: Please register below to receive the Zoom Link. \n\n\n\n\n\n\n\nOlumide Gbolahan\, MD\, MSc  \n\n\n\nAssociate Professor  \n\n\n\nDepartment of Hematology and Medical Oncology \n\n\n\n\n\n\n\nAllison Martin\, MD\, MPH \n\n\n\nAssistant Professor of Surgery at Duke University School of Medicine  \n\n\n\nAssistant Professor of Surgery at Durham Veterans Affairs Medical Center \n\n\n\n\n\n\n\nBubu Banini\, MD\, PhD   \n\n\n\nAssistant Professor\, Section of Digestive Diseases  \n\n\n\nTranslational Research Director\, Metabolic Health and Weight Management Program  \n\n\n\nAssociate Director\, Clinical and Translational Core\, Yale Liver Center \n\n\n\n\n\n\n\nLewis R. Roberts\, M.B.\, Ch.B.\, Ph.DProfessor of Medicine 
URL:https://liverfoundation.org/events/are-you-at-risk-for-liver-cancer-ask-the-experts/
LOCATION:Virtual
CATEGORIES:Programs
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2022/08/ALF-Brand-Refresh-1280x720-1.jpg
END:VEVENT
END:VCALENDAR